Literature DB >> 19217504

Colon, rectal, and anal cancers.

Gail Wilkes1, Kevan Hartshorn.   

Abstract

OBJECTIVES: To review the incidence, risk factors, staging, diagnosis, and treatment of colon, rectal, and anal cancers, as well as nursing care associated with managing patients diagnosed with these malignancies. DATA SOURCES: Published research reports, epidemiologic data, published patient management guidelines, and institution-based clinical tools.
CONCLUSIONS: Significant advances in the management of colon, rectal, and anal cancers in the past decade have extended patient survival. Further clinical research will refine current therapeutic strategies and treatment decision-making aids while minimizing symptoms of disease and treatment. IMPLICATIONS FOR NURSING PRACTICE: Nurses need to be familiar with risk factors, disease course, and current and emerging therapies to assist patients with treatment decision-making, and to anticipate and intervene in managing disease and treatment-induced problems. Early identification and management of distressing symptoms can help to avoid life-threatening effects and promote patient adherence to prescribed therapies; timely patient/family education may minimize anxiety and promote self-management.

Entities:  

Mesh:

Year:  2009        PMID: 19217504     DOI: 10.1016/j.soncn.2008.10.003

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  4 in total

1.  [Mechanical obstruction as a cause of acute abdomen. Radiological differential diagnosis].

Authors:  M Körner; U Linsenmaier; M Reiser
Journal:  Radiologe       Date:  2010-03       Impact factor: 0.635

2.  Celastrus orbiculatus extract inhibits the migration and invasion of human glioblastoma cells in vitro.

Authors:  Hao Gu; Jun Feng; Haibo Wang; Yayun Qian; Lin Yang; Jue Chen; Feng Jin; Youyang Shi; Songhua Lu; Yangqing Liu
Journal:  BMC Complement Altern Med       Date:  2016-10-06       Impact factor: 3.659

3.  Does the prognosis of colorectal cancer vary with tumor site?

Authors:  Mohamad Asghari Jafarabadi; Seyede Momeneh Mohammadi; Ebrahim Hajizadeh; Anoshirvan Kazemnejad; Seyed Reza Fatemi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2011

Review 4.  Human defensins and LL-37 in mucosal immunity.

Authors:  Mona Doss; Mitchell R White; Tesfaldet Tecle; Kevan L Hartshorn
Journal:  J Leukoc Biol       Date:  2009-10-06       Impact factor: 4.962

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.